Alli Recall Could Help Mitigate Reputation Damage In Face Of Tampering

GSK investigates tampering with its alli weight-loss drug and positions itself as a consumer advocate with a U.S. recall of the product. By showing it is “on the side of good” the firm could actually emerge from the crisis with a stronger reputation, says crisis management expert Gene Grabowski says.

GlaxoSmithKline PLC’s alli recall places patient safety ahead of sales in a way that could mitigate long-term damage to the weight-loss drug’s reputation, just as Johnson & Johnson did in its response to tampering with Tylenol in the 1980s.

GSK voluntarily recalled all lots of alli from the retail level in the U.S. and Puerto Rico March 27 –...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United States

More from North America